Prostate cancer drugs may cloud your mind: new study investigates

NCT ID NCT03016741

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study looks at how certain hormone therapies for advanced prostate cancer might affect memory, thinking, and brain structure. Researchers will use brain scans and thinking tests in 100 men to track changes over time. The goal is to understand which patients are more likely to experience mental side effects and why.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC PROSTATE CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

castration-resistant prostate carcinoma Cognitive Dysfunction dementia hormone-resistant prostate carcinoma metastatic prostate carcinoma prostate cancer prostate carcinoma Prostatic Neoplasms, Castration-Resistant

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • City of Hope Comprehensive Cancer Center

    Los Angeles, California, 91010, United States

  • Northwestern University

    Chicago, Illinois, 60611, United States

  • Tulane Cancer Center

    New Orleans, Louisiana, 70112, United States

  • University of Minnesota: Masonic Cancer Center

    Minneapolis, Minnesota, 55455, United States

  • Vanderbilt-Ingram Cancer Center

    Nashville, Tennessee, 37232, United States